Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > short interest

<< Previous

Bullboard Posts

Next >>

Comment by Angler101on May 07, 2024 6:08pm

95 Views

Post# 36027731

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:short interest

Overthrow the govt.?....as in insurrection?...funny, one would think somebody guilty of such an act would have been charged with it...I don't see any account of where Trump has been convicted of insurrection, let alone even tried or even charged, although the mainstream propaganda media constantly accuses him of it.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec